New treatments, such as targeted therapies or immunotherapy, are integrated into guidelines after rigorous evaluation of the evidence supporting their efficacy and safety. Clinical trials and real-world data play a significant role in assessing these new treatments, ensuring they offer substantial benefits over existing options.
